Trial Information

Inclusion Criteria:

- All diagnoses admitted for a first allogeneic myeloablative Blood and marrow
transplantation (BMT)

- Adult subjects greater or equal to 18 year of age. There are no gender or ethnic
restrictions

- Karnofsky performance status >= 70%.

- Admitted to E1 Day-7 (+/- 3 days).

- Patients must be informed of this study and must sign and give written informed
consent in accordance with institutional and federal guidelines.

Exclusion Criteria:

- Patients with musculoskeletal, neurological, cardiovascular, and pulmonary
impairments will be excluded. Cardiovascular and pulmonary status will be confirmed
prior to transplantation by electrocardiogram, echocardiogram, and pulmonary function
tests. Musculoskeletal and screening for neurological impairments will be assessed by
Karnovsky score >=70% and by Physical Therapy assessment.

Start Date:

Completion Date:

Related Keywords:

Name

Location

We are a Cancer Social Network, Resource Directory & Education Hub supporting all those affected by cancer. knowcancer.com is intended to be solely for informational purposes and should not be a substitute for professional medical advice, diagnosis or treatment.